Association between body mass index and diabetes mellitus in tuberculosis patients in China: a community based cross-sectional study by unknown
RESEARCH ARTICLE Open Access
Association between body mass index and
diabetes mellitus in tuberculosis patients in
China: a community based cross-sectional
study
Jing Cai1, Aiguo Ma1*, Qiuzhen Wang1, Xiuxia Han1, Shanliang Zhao2, Yu Wang3, Evert G. Schouten4
and Frans J. Kok4
Abstract
Background: We planned to determine the association of body mass index (BMI) with diabetes mellitus (DM) and
impaired fasting glucose (IFG) in Chinese pulmonary tuberculosis (PTB) patients.
Methods: 3,505 newly-diagnosed PTB patients registered in PTB clinics in Linyi of China between September 2010
and March 2013 were enrolled. DM and IFG were identified based on fasting plasma glucose levels. ROC analysis
was used to predict the ability of screening of BMI for DM and IFG in PTB patients.
Results: Compared with 18.5–23.9 kg/m2, patients with DM and IFG had significantly increased trends when BMI ≥
24.0 kg/m2, and aORs were 2.28 (95%CI 1.44–3.60) and 1.30 (95%CI 1.04–1.64), respectively. After adjustment for age,
gender, and educational level, there was an increased odd in BMI ≥ 23.41 kg/m2 for IFG, and a decreased odd in
BMI < 19.82 kg/m2 for DM (p < 0.05). The cut-offs of BMI for screening IFG and DM in PTB patients were 22.22 kg/m2
(AUC 0.56) and 22.34 kg/m2 (AUC 0.59).
Conclusions: In PTB patients, BMI is significantly associated with IFG and DM. However, the predictive power of
BMI was not sufficient, so it may only be a limited screening tool for DM and IFG among PTB patients in China.
Keywords: Fasting plasma glucose, Receiver operating characteristic, Area under the curve
Background
The co-morbidity of diabetes mellitus (DM) and pulmon-
ary tuberculosis (PTB) represents a double burden with
significant public health implications [1, 2]. Globally,
although the incidence of PTB is slowly decreasing, an in-
crease is seen in the proportion of PTB cases with DM.
Moreover, the prevalence of DM steadily increases, espe-
cially in developing countries where PTB is highly
endemic [3, 4]. Baker conducted a meta-analysis of obser-
vational studies about the association between DM and
TB disease outcomes, and showed that DM was associated
with worse treatment outcomes, and increased the risk of
failure, death, and relapse among patients with PTB.
Therefore, more attention should be paid to the control
and prevention of PTB patients with DM [5].
Also, patients with impaired fasting glucose (IFG) are
more prone to progress to the DM stage -approximately
8.8% per year in China [6, 7]- in the absence of interven-
tional measures. In developing countries, the nutritional
status has improved along with the economic growth. A
number of studies have provided strong evidence of an
association between patients who are overweight or
obese and risk of DM [8–10]. The effect of BMI on DM
has primarily focused on patients without other diseases.
A low BMI is a significant individual risk factor for de-
velopment of recent active TB [11], and patients who are
overweight have a decreased incidence of TB [12]. Stud-
ies involving the association between BMI and DM or
IFG in PTB patients are limited [13], and no data are
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available on using BMI cut-offs to predict DM or IFG in
PTB patients.
We designed this cross-sectional study using primary
data to explore the association of BMI with DM or IFG in
PTB patients in China, and to determine the optimal BMI




A total of 3,505 PTB patients, 18-45 years of age, were
selected from counties of Linyi in Shandong province,
China. All the PTB patients were newly-diagnosed and
registered for Directly Observed Treatment, Short
Course (DOTS) in PTB clinics between September 2010
and March 2013, and also were diagnosed in the PTB
clinic of each county by X-ray and sputum smear exam-
ination. All participants have written informed consent.
Detection of indices
DM was diagnosed by World Health Organization cri-
teria based on the fasting plasma glucose (FPG) level
(World Health Organization, 1999). The diagnosis of
IFG was based on criteria for the classification of glucose
tolerance based on the FPG level, which was defined as
a FPG range from 5.6–6.9 mmol/L (American Diabetes
Association, 2014). The participants fasted for 8–10 h
before the blood testing.
Basic information and anthropometric indices of all
patients were collected, such as age, gender, educational
level, weight, and height. The BMI (kg/m2) was calcu-
lated using the following formula: BMI = weight (kg)/
height (m)2. Underweight, normal weight, overweight,
and obese categories were defined using the modified
criteria for the Chinese population; the BMI cut-off
values were 18.5 kg/m2, 24.0 kg/m2, and 28.0 kg/m2, re-
spectively [14].
Blood lipids were also determined in fasting venous
blood samples using an automatic biochemical analyzer
in each clinic, and included triglycerides (TG), total
cholesterol (TCHO), and high-density lipoprotein (HDL)
levels.
Statistical analysis
SPSS version 17.0 (SPSS, Inc. Chicago, IL) was used
for statistical analyses. The characteristics of PTB pa-
tients in the DM, IFG and normal FPG groups and
inter-quartile range (IQR) of BMI were compared and
analyzed. The mean and standard deviation for con-
tinuous variables, such as age, BMI, and blood lipid
content, and proportions for categorical variables, in-
cluding the prevalence of DM or IFG, the percentage
of age group, gender, and educational level, are re-
ported. One-way analysis of variance was used to test
continuous variables. A chi-square test was used to
compare categorical variables. Multinomial logistic re-
gression analyses were performed, and the variables
for inclusion in the multivariate model were chosen
based on plausibility and variables with P values
<0.05 on univariate analysis were entered into the
multivariate analysis. Receiver operating characteristic
(ROC) analysis was used to predict the ability of diag-
nosis of BMI for DM and IFG in PTB patients. The
sensitivity, specificity, positive predictive value (PPV),
negative predictive value (NPV), positive likelihood
ratio (PLR), negative likelihood ratio (NLR) and You-
den’s index were used for ROC analysis. Youden’s
index is a single statistic that captures the perform-
ance of a dichotomous diagnostic test. It was defined
for all points of the ROC curve, and the maximum
value of the index was used as a criterion for select-
ing the optimum cut-off point. Youden’s index = Sen-
sitivity + Specificity – 1. All variables were checked
for collinearity. Independent variables included age
(divided into two categories [18–30 and 31–45
years]), gender, educational level, BMI (divided into
three categories [<18.5 kg/m2 as underweight, 18.5–
23.9 kg/m2 as normal weight, and ≥ 24.0 kg/m2 as




A total of 3 505 PTB patients were included in our study
(18–45 years of age), among whom 96 and 529 had co-
existing DM and IFG, respectively. The mean age was
31 · 8 years for all PTB patients, and the mean age in the
PTB + DM group was the highest (P < 0.05). In the PTB
+ IFG group, 65.2% were male, which was more than the
PTB group (57.5%, P < 0.05). The percentage of patients
with a high school or higher educational level in the PTB
+DM and PTB + IFG groups were lower than the PTB
group (P < 0.05). BMI means and the proportion of over-
weight or obese patients in the PTB +DM and PTB + IFG
groups were higher than the PTB group (P < 0.05). The
means of TG and TCHO were 1.6 mmol/L and 4.8 mmol/
L in the PTB +DM group, respectively, which were higher
than the PTB + IFG and PTB groups (P < 0.05).
Multivariate logistic regression analysis of DM or IFG
in PTB patients is shown in Table 1. PTB patients in the
younger age group and patients with a high educational
level, had an odds ratio (OR) of the presence of DM and
IFG that was significantly lower than 1.0 (P < 0.05).
Overweight or obese patients had significantly higher
odds ratios of DM and IFG (OR = 2.28, 95% confidence
interval [CI] =1.44–3.60; OR = 1.30, 95% CI = 1.04–1.64,
respectively). In addition, male gender was positively as-
sociated with the IFG (OR = 1.38, 95% CI = 1.14–1.68).
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Prevalence of IFG or DM in PTB patients as a function of
BMI quartiles
The participants were divided into four groups based
on the BMI baseline quartiles, as follows: Q1,
<19.82 kg/m2; Q2, 19.82 kg/m2; Q3, 21.45 kg/m2; and
Q4, 23.41 kg/m2 (Fig. 1). There was an increasing
prevalence of IFG among the four groups (11.6%,
14.4%, 16.3%, and 18.0% respectively); in different age
and gender categories, the prevalence of IFG was in-
creased from Q1 to Q4. The prevalence of DM in the
Q2 group was much lower than the Q4 group (P <
0.05); the prevalence in the patients 31–45 years of
age and males were also the same trends.
The percentages of different BMI levels among the
PTB + DM, PTB + IFG, and PTB groups are shown in
Fig. 2. The distributions of the three groups were almost
overlapping and all similar to normal distributions. At
lower BMI (<21.0 kg/m2), the percentage in the PTB
group was somewhat higher; at higher BMI, it was lower
than the PTB + IFG group and PTB + DM group.
Odds ratios of BMI quartiles for IFG or DM
The univariate and multivariate odds ratios for IFG
and DM based on BMI quartiles are shown in Table 2.
For IFG univariate ORs in Q3 and Q4 (model 1) were
significantly greater than 1.0. After adjustment for
age, gender, and educational level (model 4), only the
OR in Q4 was still significant. For DM in model 1,
the OR in Q4 was significantly greater than 1.0. After
adjustment for age, gender, and educational level, only
the OR in Q1 was significantly smaller than 1.0.
ROC of BMI for IFG or DM in PTB patients
The results of ROC analysis showed that BMI might be
a weak potential predictor for IFG or DM in PTB pa-
tients (Table 3). With respect to IFG, the area under the
ROC curve was 0.56 for all PTB patients and 0.57 for
male patients. The optimal BMI cut-off for IFG was
identified as 22.22 kg/m2 in all patients and 22.23 kg/m2
in males; and the PPV, NPV, PLR and NLR were 0.70,
0.38, 1.17 and 0.81 for all patients and 0.73, 0.38, 1.36
and 0.80 for males, respectively. With respect to DM,
the area under the ROC curve was 0.59 for all PTB pa-
tients, 0.58 for patients 31–45 years of age, and 0.61 for
males. The optimal BMI cut-off for DM was 22.34 kg/
m2 in all patients, 22.53 kg/m2 in patients 31–45 years
of age, and 22.41 kg/m2 in males; and the PPV, NPV,
PLR and NLR were 0.77, 0.42, 1.58 and 0.65 for all pa-
tients, 0.78, 0.39, 1.45 and 0.64 for 31–45 years of age,
0.78, 0.43, 1.66 and 0.60 for males, respectively.
Table 1 Characteristics of PTB patients and odds ratios of having impaired fasting glucose (IFG) or diabetes mellitus (DM)
Variables PTB + DM group (n = 96) PTB + IFG group (n = 529) PTB group (n = 2880)
(ref)
p-value
Mean ± SD/N (%) OR (95% CI) P-value Mean ± SD/N (%) OR (95% CI) P-value Mean ± SD/N (%)
Age, years 36.39 ± 7. 0 * † – – 33.9 ± 8.0 * – – 31.2 ± 8.3 <0.001
Age group, n (%) <0.001
18–30 years 21 (21.9) 0.26 (0.16–0.42) <0.001 190 (35.9) 0.51 (0.42–0.62) <0.001 1506 (52.3)
31–45 years 75 (78.1) 1 – 339 (64.1) 1 – 1374 (47.7)
Gender, n (%) 0.004
Male 56 (58.3) 1.03 (0.68–1.56) 0.876 345 (65.2) 1.38 (1.14–1.68) 0.001 1657 (57.5)
Female 40 (41.7) 1 – 184 (34.8) 1 – 1223 (42.5)
Education, n (%) <0.001
High school or higher 16 (16.7) 0.19 (0.08–0.46) <0.001 119 (22.5) 0.37 (0.24–0.58) <0.001 892 (31.0)
Primary or middle school 72 (75.0) 0.41 (0.19–0.87) 0.021 379 (71.6) 0.55 (0.36–0.85) 0.006 1902 (66.0)
Illiteracy 8 (8.3) 1 – 31 (5.9) 1 – 86 (3.0)
TG, mmol/L 1.6 ± 1.0 * † – – 1.3 ± 1.0 – – 1.2 ± 1.0 <0.001
TCHO, mmol/L 4.8 ± 1.2 * † – – 4.4 ± 1.1 – – 4.3 ± 1.3 0.002
HDL, mmol/L 1.7 ± 0.8 – – 1.6 ± 0.7 – – 1.5 ± 2.5 0.575
BMI, kg/m2 22.6 ± 3.4 * – – 22.2 ± 2.9 * – – 21.6 ± 2.8 <0.001
BMI group, n (%) <0.001
Underweight 12 (12.5) 1.46 (0.77–2.76) 0.244 44 (8.3) 0.79 (0.56–1.10) 0.157 314 (10.9)
Overweight or obese 30 (31.3) 2.28 (1.44–3.60) <0.001 117 (22.1) 1.30 (1.04–1.64) 0.024 503 (17.5)
Normal weight 54 (56.2) 1 – 368 (69.6) 1 – 2063 (71.6)
* Compared with PTB group, P < 0.05; † Compared with PTB + IFG group, P < 0.05; – The values could not be calculated; SD standard deviation, ref reference
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Discussion
In this survey of Chinese adults (18–45 years of age), we
showed that overweight and obesity were positively asso-
ciated with DM and IFG in PTB patients. The preva-
lence of DM and IFG was higher when the BMI was ≥
23.41 kg/m2 (Q4). Until now the optimal BMI cut off
point for IFG and DM screening among PTB patients
has not been estimated in China. Based on the current
study, the optimal BMI cut-offs for predicting DM and
IFG were 22.22 kg/m2 and 22.34 kg/m2, respectively.
After adjusted for the associated factors, including
young age, high educational level, and excess weight,
BMI was still a risk factor for DM or IFG in PTB pa-
tients. In a previous cohort study [15], the incidence of
DM was mainly associated with overweight and obesity
in China (28.3% among men and 31.3% among women).
However, a inverse association and dose–response rela-
tionship between the incidence of TB and BMI up to
30.0 kg/m2 was shown in a previous meta-analysis [16].
The relative risk of TB in underweight patients (BMI <
Fig. 1 Prevalence of IFG or DM in PTB patients between BMI quartiles at different age and gender groups. a showed the prevalence of IFG in PTB
patients between IQR of BMI at different age and gender groups. b showed the prevalence of IFG in PTB patients between IQR of BMI at different age
and gender groups. ■ compared with Q3, P < 0.05; ○ compared with Q4, P < 0.05
Fig. 2 The constituent ratio of different BMI level among PTB + DM, PTB + IFG, PTB groups
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18.5 kg/m2) compared to normal weight patients was es-
timated to be 3.2 (95% CI = 3.1–3.3) [17]. Meanwhile, an
association between abnormal weight and elevated glu-
cose (DM and IFG) may still exist. A survey adminis-
tered in 49 developing countries showed that not only
overweight, but also underweight might be involved in
the pathogenesis of diabetes [18]. Thus, overweight and
obesity in PTB patients should not be overlooked,
whether or not it regards only a small proportion of
PTB patients.
In the model adjusted by all of the relevant risk fac-
tors, a BMI in the 19.82–21.45 kg/m2 range was nega-
tively associated with DM in PTB patients, and a BMI >
23.41 kg/m2 was positively associated with IFG. More-
over, for a BMI ≥ 23.41 kg/m2, the prevalence of DM and
IFG in PTB patients was much higher in our study. A
cross-sectional study carried out in Spain showed that
the prevalence of DM in overweight or obese patients
was 23.6%, and the higher the BMI, the higher the
prevalence of DM [19]. In the current study, some dif-
ferences in the BMI associations still existed. Specifically,
when the BMI was < 19.82 kg/m2 (Q1), the prevalence of
DM in PTB patients presented slightly decreased, al-
though the differences were not significant. This finding
might be attributable to the impact of PTB. Abundant
epidemiologic evidence has indicated that low BMI is a
risk factor for PTB, and the biological mechanism
underlying the relationship has been well-described by
induced impairment of cellular immunity [20]. In
addition, underweight patients might also be involved in
the pathogenesis of DM through direct and indirect
mechanisms [21]. Therefore, we should pay more









IFG Model 1 1.00 1.27 (0.96–1.69) 2.49 (1.14–1.97) * 1.73 (1.32–2.27) *
Model 2 1.00 1.15 (0.87–1.53) 1.28 (0.96–1.69) 1.37 (1.03–1.82) *
Model 3 1.00 1.12 (0.84–1.48) 1.25 (0.94–1.65) 1.37 (1.03–1.81) *
Model 4 1.00 1.12 (0.84–1.50) 1.27 (0.96–1.69) 1.41 (1.06–1.88) *
DM Model 1 1.00 0.53 (0.25–1.11) 1.21 (0.67–2.19) 2.11 (1.23–3.61) *
Model 2 1.00 0.43 (0.20–0.90) * 0.87 (0.47–1.59) 1.31 (0.75–2.31)
Model 3 1.00 0.43 (0.20–0.90) * 0.86 (0.47–1.59) 1.31 (0.75–2.31)
Model 4 1.00 0.44 (0.21–0.92) * 0.90 (0.49–1.66) 1.39 (0.79–2.46)
Model 1 unadjusted; Model 2 was adjusted by age; Model 3 was adjusted by Model 2 + gender; Model 4 was adjusted by Model 3 + educational level; *By multinomial
logistic regression analyses, P < 0.05
Table 3 Receiver Operator Curve analysis of the predictive value of BMI for impaired fasting glucose (IFG) and diabetes mellitus
(DM) in categories of gender and age in PTB patients
SE AUC (95%CI) p-value Sensitivity Specificity PPV NPV PLR NLR Youden’s index Associated criterion
IFG Total 0.01 0.56 (0.53–0.58) <0.001 0.61 0.48 0.70 0.38 1.17 0.81 0.09 22.22
Age
18–30 years 0.02 0.54 (0.49–0.58) 0.104 – – – – – – – –
31–45 years 0.02 0.53 (0.49–0.56) 0.124 – – – – – – – –
Gender
Male 0.02 0.57 (0.54–0.60) <0.001 0.49 0.64 0.73 0.38 1.36 0.80 0.13 22.23
Female 0.02 0.53 (0.48–0.58) 0.188 – –
DM Total 0.03 0.59 (0.53–0.66) 0.002 0.60 0.62 0.77 0.42 1.58 0.65 0.22 22.34
Age
18–30 years 0.07 0.50 (0.37–0.63) 0.977 – – – – – – – –
31–45 years 0.04 0.58 (0.50–0.65) 0.024 0.64 0.56 0.78 0.39 1.45 0.64 0.20 22.53
Gender
Male 0.04 0.61 (0.53–0.70) 0.004 0.63 0.62 0.78 0.43 1.66 0.60 0.25 22.41
Female 0.05 0.56 (0.46–0.67) 0.184 – – – – – – – –
PPV positive predictive value, NPV negative predictive value, PLR positive likelihood ratio, NLR negative likelihood ratio, SE Standard Error, AUC area under the curve;
Youden’s index = Sensitivity + Specificity− 1; – When p > 0.05, there was no appropriate cut-off by ROC analysis, so the Youden’s index and associated criterion could not
be shown
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attention to the factors associated with underweight,
overweight, and obesity, who favor high prevalence of
DM and IFG in PTB patients.
We were able to establish BMI cut-off values for
DM and IFG in PTB patients in the current study.
Although BMI might not be the strongest risk factor
to screen undiagnosed DM compared with age, waist
circumference, and a family history of DM [22], it is
an easy to acquire anthropometric index for the pre-
diction of DM. With respect to adults, the optimal
BMI cut-off value for predicting the presence of DM
was 23.3 kg/m2 for men and 24.0 kg/m2 for women
[23]. A cross-sectional study conducted in northeast
Chinese adults showed that combined with the waist-
to-height ratio, a maximal BMI ≥ 23.0 kg/m2 for DM
and ≥ 22.0 kg/m2 for glucose tolerance abnormalities
were better anthropometric indices [24]. Also, the San
Antonio Heart Cohort Study reported that BMI and
waist circumference had equal power in predicting
development of metabolic syndrome in non-Hispanic
Whites and Mexican Americans [25]; thus, BMI is
possibly an appropriate predictor for pathoglycemia.
Of note, the optimal BMI cut-off points in our study
were lower than other studies, which might because
PTB patients were more likely to have a low BMI
[11], and in young patients (18–45 years old), a lower
BMI was more common [26].
There were some limitations in our study. First,
there were some limitations in the generalizability of
our findings: the age range and only Chinese partici-
pants. The age range in our survey was 18–45 years,
which comprised young and middle-aged adults in
China. Because there were no elderly in our study,
which comprise a high-risk group and have a higher
prevalence than young and middle-aged adults [27],
the prevalence of DM and IFG would be low. And
then, the results of this study were applied to Chinese
population, so there might be different results in
other countries. Second, Youden’s index was low,
which meant the false-positive and false-negative
values were high for BMI in predicting DM and IFG
in PTB patients.
Conclusions
In conclusion, the present study revealed that BMI
might be a limited screening tool for DM and IFG in
PTB patients in Chinese young and middle-aged people.
However, the predictive power of BMI was still poor.
This study is only a prelude to the upcoming research
in co-existing infectious diseases and chronic non-
communicable diseases, especially in Chinese popula-
tions. Further studies are warranted to verify the
effects of nutritional status on the co-morbidity of
these two diseases.
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